18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer

Journal of Nuclear Medicine

Volumn 42, Issue 11, 2001, Pages 1596-1604

  Hicks, R J ^a   Kalff, V ^a   MacManus, M P ^a   Ware, R E ^a   Hogg, A ^a   McKenzie, A F ^a   Matthews, J P ^a   Ball, D L ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

FDG; Impact; Lung cancer; PET; Prognosis; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS;

EID: 0035209364     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cancer statistics, 1996
2. Characteristics of 49 patients who survived for 5 years following radical radiation therapy for non-small cell lung cancer: The potential for cure
3. A randomized trial of induction chemotherapy plus high-dose radiation vs radiation alone in stage III NSCLC
4. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group
5. Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node sampling
6. 18F-fluorodeoxyglucose positron emission tomography
7. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging
8. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: A comparative study with x-ray computed tomography
9. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: Implications for radical radiotherapy
10. Continuous-slice PENN-PET: A positron tomograph with volume imaging capability
11. Standards for performance measurements of PET scanners: Evaluation with the UGM PENN-PET 240H scanner
12. 137CS in whole body PET imaging
13. Revisions to the international system for staging lung cancer
14. PET in lung cancer
15. The clinical impact of F-18 FDG positron emission tomography (PET) in patients with non-small cell lung cancer: A prospective study
16. Reported management of lung cancer in Victoria in 1993: Comparison with best practice
17. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytical comparison of PET and CT
18. Preoperative staging of non-small-cell lung cancer with positron-emission tomography
19. Randomized controlled trials are not appropriate for imaging technology evaluation
20. Randomized controlled trial (RCT) to evaluate the cost-effectiveness of positron emission tomography (PET) added to conventional diagnosis in non-small cell lung cancer (NCLC)